LB Pharmaceuticals Inc
LBRX
$29.66
-$1.75-5.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.05M | -11.47M | -3.56M | -5.09M | -5.31M |
| Total Depreciation and Amortization | 82.00K | 85.00K | 81.00K | 77.50K | 79.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.43M | 2.81M | 199.00K | 157.00K | -132.00K |
| Change in Net Operating Assets | -6.75M | -9.53M | -97.00K | -2.01M | -2.77M |
| Cash from Operations | -23.29M | -18.10M | -3.37M | -6.87M | -8.13M |
| Capital Expenditure | -32.00K | -40.00K | 0.00 | -6.00K | -21.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -44.84M | 2.50M | 5.00M |
| Cash from Investing | -32.00K | -40.00K | -44.84M | 2.49M | 4.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.03M | 0.00 | 328.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.20M | -1.17M | -24.27M | -- | -- |
| Cash from Financing | 93.83M | -1.17M | 303.73M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.51M | -19.31M | 255.52M | -4.37M | -3.15M |